Cargando…

Risdiplam for spinal muscular atrophy

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427635/
https://www.ncbi.nlm.nih.gov/pubmed/36110169
http://dx.doi.org/10.18773/austprescr.2022.041
_version_ 1784778950412599296
collection PubMed
description
format Online
Article
Text
id pubmed-9427635
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-94276352022-09-14 Risdiplam for spinal muscular atrophy Aust Prescr New Drugs NPS MedicineWise 2022-07-07 2022-08 /pmc/articles/PMC9427635/ /pubmed/36110169 http://dx.doi.org/10.18773/austprescr.2022.041 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Risdiplam for spinal muscular atrophy
title Risdiplam for spinal muscular atrophy
title_full Risdiplam for spinal muscular atrophy
title_fullStr Risdiplam for spinal muscular atrophy
title_full_unstemmed Risdiplam for spinal muscular atrophy
title_short Risdiplam for spinal muscular atrophy
title_sort risdiplam for spinal muscular atrophy
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427635/
https://www.ncbi.nlm.nih.gov/pubmed/36110169
http://dx.doi.org/10.18773/austprescr.2022.041